We sought to confirm that 3xTg-AD mice in our cohort (6 – 10.5 month old) exhibited deposition of human tTau and p181-Tau (known to begin at six months of age, with robust detection at 12 months of age) [25,34]. This evidence concerns the gene MAPT and Alzheimer disease.